Biofarm Overview

  • Founded
  • 1921

Founded
  • Status
  • Public

  • Employees
  • 393

Employees
  • Stock Symbol
  • BIO

Stock Symbol
  • Share Price
  • $0.14

  • (As of Tuesday Closing)

Biofarm General Information

Description

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.

Contact Information

Website
www.biofarm.ro
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
BSE
Primary Office
  • Strase Logofătul Tăutu nr. 99
  • Sector 3
  • Bucharest, 031212
  • Romania
+40 021 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biofarm Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.14 $0.14 $0.11 - $0.19 $140M 985M 34.2K $0.02

Biofarm Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 88,414 159,845 86,274 62,632
Revenue 58,918 57,398 50,939 46,028
EBITDA 21,021 19,688 17,604 16,257
Net Income 15,600 14,492 12,772 11,990
Total Assets 91,019 95,640 94,015 81,061
Total Debt 129 148 157 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biofarm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biofarm‘s full profile, request access.

Request a free trial

Biofarm Executive Team (4)

Name Title Board Seat Contact Info
Catalin Vicol Board Member & General Manager
Laura Boer Chief Accounting Officer
Liviu Visan Administrative Manager
You’re viewing 3 of 4 executive team members. Get the full list »

Biofarm Board Members (5)

Name Representing Role Since
000000 0000000000 Biofarm Chairman & Board Member 000 0000
0000000 00000 Biofarm Board Member & General Manager 000 0000
0000000-000000 000 Biofarm Board Member 000 0000
000000 00000 Biofarm Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Biofarm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biofarm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biofarm‘s full profile, request access.

Request a free trial

Biofarm ESG

Risk Overview

Risk Rating

Updated November, 10, 2022

32.78 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,638

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 1,008

Rank

00.0

Percentile

Pharmaceuticals

Subindustry

00 of 473

Rank

00.00

Percentile

To view Biofarm’s complete esg history, request access »